Financhill
Sell
22

CC Quote, Financials, Valuation and Earnings

Last price:
$17.57
Seasonality move :
9.02%
Day range:
$17.25 - $17.80
52-week range:
$15.10 - $32.70
Dividend yield:
5.7%
P/E ratio:
35.80x
P/S ratio:
0.46x
P/B ratio:
3.99x
Volume:
1.1M
Avg. volume:
1.7M
1-year change:
-44.83%
Market cap:
$2.6B
Revenue:
$6B
EPS (TTM):
$0.49

Analysts' Opinion

  • Consensus Rating
    The Chemours has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $24.22, The Chemours has an estimated upside of 38.1% from its current price of $17.54.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $17.54.

Fair Value

  • According to the consensus of 7 analysts, The Chemours has 38.1% upside to fair value with a price target of $24.22 per share.

CC vs. S&P 500

  • Over the past 5 trading days, The Chemours has underperformed the S&P 500 by -8.1% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • The Chemours does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • The Chemours has grown year-over-year revenues for 1 quarter straight. In the most recent quarter The Chemours reported revenues of $1.5B.

Earnings Growth

  • The Chemours earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter The Chemours reported earnings per share of -$0.18.
Enterprise value:
6.1B
EV / Invested capital:
1.29x
Price / LTM sales:
0.46x
EV / EBIT:
19.64x
EV / Revenue:
1.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-8.99x
Price / Operating cash flow:
430.53x
Enterprise value / EBITDA:
10.01x
Gross Profit (TTM):
$1.1B
Return On Assets:
0.99%
Net Income Margin (TTM):
1.34%
Return On Equity:
10.59%
Return On Invested Capital:
1.63%
Operating Margin:
8%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $7B $6B $5.8B $1.5B $1.5B
Gross Profit $1.8B $1.3B $1.1B $273M $286M
Operating Income $994M -$130M $373M $57M $120M
EBITDA $1.6B $176M $606M $144M $117M
Diluted EPS $5.60 -$2.06 $0.49 $0.08 -$0.18
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $2.6B $3.4B $3.5B $3.7B $3.1B
Total Assets $6.9B $7.5B $7.7B $7.9B $7.5B
Current Liabilities $1.3B $1.8B $2B $2.2B $1.8B
Total Liabilities $6.2B $6.5B $6.5B $7.2B $6.8B
Total Equity $734M $999M $1.3B $757M $659M
Total Debt $4.1B $3.9B $3.5B $4B $4B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $802M $235M -$289M $131M $139M
Cash From Investing $203M -$164M -$376M $58M -$75M
Cash From Financing -$690M -$14M -$126M $324M -$27M
Free Cash Flow $479M -$67M -$675M $45M $63M
CC
Sector
Market Cap
$2.6B
$18.8M
Price % of 52-Week High
53.64%
57.39%
Dividend Yield
5.7%
0%
Shareholder Yield
2.21%
1.61%
1-Year Price Total Return
-44.83%
-18.92%
Beta (5-Year)
1.798
1.064
Dividend yield:
5.7%
Annualized payout:
$1.00
Payout ratio:
193.51%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $18.19
200-day SMA
Sell
Level $22.53
Bollinger Bands (100)
Sell
Level 17.99 - 20.57
Chaikin Money Flow
Buy
Level 75M
20-day SMA
Sell
Level $20.09
Relative Strength Index (RSI14)
Sell
Level 32.02
ADX Line
Buy
Level 0.95
Williams %R
Buy
Level -93.8431
50-day SMA
Sell
Level $19.65
MACD (12, 26)
Sell
Level -0.69
25-day Aroon Oscillator
Sell
Level -64
On Balance Volume
Neutral
Level 21.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.5593)
Sell
CA Score (Annual)
Level (-1.9927)
Buy
Beneish M-Score (Annual)
Level (-3.132)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.3918)
Sell
Piotroski F Score (Annual)
Level (3)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Stock Forecast FAQ

In the current month, CC has received 1 Buy ratings 6 Hold ratings, and 0 Sell ratings. The CC average analyst price target in the past 3 months is $24.22.

  • Where Will The Chemours Stock Be In 1 Year?

    According to analysts, the consensus estimate is that The Chemours share price will rise to $24.22 per share over the next 12 months.

  • What Do Analysts Say About The Chemours?

    Analysts are divided on their view about The Chemours share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Chemours is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is The Chemours's Price Target?

    The price target for The Chemours over the next 1-year time period is forecast to be $24.22 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is CC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for The Chemours is a Hold. 6 of 7 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CC?

    You can purchase shares of The Chemours via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Chemours shares.

  • What Is The The Chemours Share Price Today?

    The Chemours was last trading at $17.57 per share. This represents the most recent stock quote for The Chemours. Yesterday, The Chemours closed at $17.54 per share.

  • How To Buy The Chemours Stock Online?

    In order to purchase The Chemours stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
52
TSLL alert for Dec 24

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
73
PSIX alert for Dec 24

Power Solutions International [PSIX] is up 27.42% over the past day.

Sell
31
SOXL alert for Dec 24

Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock